In early May 2025, President Donald Trump proposed a new tariff policy targeting foreign-made films. In a post on his social media platform, President Trump announced plans to impose a 100% tariff on all movies produced outside the United States and imported for American audiences. The move, he said, is necessary to protect American jobs and the domestic film industry, which he said is being undercut by foreign governments offering generous production incentives to lure…
On May 12, 2025, the United States and China announced their agreement to reduce the high tariff rates imposed on each other’s goods since early April while they enter into consultations to resolve their respective trade concerns. The agreement remains a temporary measure rather than a comprehensive resolution. US Tariff Modifications The United States will, for an initial period of 90 days, reduce the “reciprocal” tariff rate on Chinese goods from 125% to the baseline…
On April 17, 2025, the United States Trade Representative (USTR) issued a final notice of action in its investigation under Section 301 of the Trade Act of 1974 of China’s maritime, logistics, and shipbuilding sectors for abusive and discriminatory practices associated with their sector dominance. In addition to introducing new fees and restrictions on Chinese-built, -owned, and -operated vessels, the notice of action also introduces new requirements on liquified natural gas (LNG) tankers and proposes…
On May 12, 2025, the White House issued a wide-reaching Executive Order (“EO“) titled “Delivering Most Favored Nation Prescription Drug Pricing to American Patients” for the stated purpose of ensuring that American patients will have access to the most-favored-nation (“MFN“) price for prescription drugs and biologics.1 This EO came out about one month after the release of EO No. 14273 titled “Lowering Drug Prices by Once Again Putting Americans First” (April 15, 2025) which outlined…
The United Kingdom (UK) and the United States (US) have concluded a trade deal covering a range of products and promoting market access for goods. In response to the recent additional tariffs adopted by the US administration, both countries agreed to the following: Additionally, the UK-US trade deal includes: The US administration has also announced that this trade deal includes streamlined customs procedures for US exports, the creation of a secure supply chain for pharmaceutical…
In briefThe US Department of Commerce (“Commerce”) has initiated a Section 232 national security investigation into the imports of pharmaceuticals and pharmaceutical ingredients. This investigation aims to determine whether these imports threaten US national security. The scope of the investigation includes finished drug products, medical countermeasures, critical inputs such as active pharmaceutical ingredients (APIs), key starting materials, and derivative products of these items. Commerce may restrict imports of these products through tariffs, quotas, or other…
Following our previous post here, we provide an update on the current developments in this area. On April 2, 2025, the US administration announced reciprocal tariffs on all imports into the United States (see here). As it has been widely reported, pharmaceutical products were exempted from these tariffs whereas medical devices were not. Subsequently, on April 9, 2025, the administration announced a 90-day postponement of the reciprocal tariffs for most countries except for China. For…
Following the 90-day pause by President Trump on the individualized reciprocal tariffs (see our blog post here), the European Union (EU) followed suit and introduced a 90-day postponement of its retaliatory tariffs aimed at the US. This decision was made to allow both parties to engage in further negotiations and potentially reach a more amicable trade agreement. European Commission President Ursula von der Leyen welcomed President Trump’s decision, stating that the pause would help stabilize…
Yesterday, President Trump announced a 90-day postponement of the individualized reciprocal tariffs for most countries (see our blog post on these tariffs here), with the notable exception of China. This decision comes amidst ongoing global trade tensions and aims to provide temporary relief to international trade partners. However, the baseline tariff of 10% for most countries worldwide, which took effect on April 5, 2025, remains in place without a specified end date. China had previously indicated…
Introduction Yesterday Commissioner Maroš Šefčovič at the Foreign Affairs Council (Trade) held a press conference following the recent developments following Trump’s “Liberation Day” Tariffs Announcement (see our blog post on that topic here). Commissioner Šefčovič addressed the current trade landscape between the European Union (EU) and the United States (US), highlighting both the challenges and opportunities for strategic collaboration. The Impact of Tariffs on EU Exports Approximately €380 billion worth of EU exports to the US,…